Search

Your search keyword '"Arita J"' showing total 471 results
Start Over Author "Arita J"
471 results on '"Arita J"'

6. Liver Resection for Multiple Hepatocellular Carcinomas

Author

Kokudo, T., primary, Ishizawa, T., additional, Nagata, R., additional, Ichida, A., additional, Mihara, Y., additional, Kawaguchi, Y., additional, Akamatsu, N., additional, Kaneko, J., additional, Arita, J., additional, and Hasegawa, K., additional

Published
2022
Full Text
View/download PDF

9. Impact of Board Certification and Adherence to Clinical Practice Guidelines for Liver Cancer on Post-Hepatectomy Mortality Rate in Japan: A Questionnaire Survey of Departments Registered with the National Clinical Database

Author

Arita, J., primary, Yamamoto, H., additional, Kokudo, T., additional, Hasegawa, K., additional, Miyata, H., additional, Toh, Y., additional, Gotoh, M., additional, Kokudo, N., additional, Kakeji, Y., additional, and Seto, Y., additional

Published
2022
Full Text
View/download PDF

22. Performance of a modified three‐level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity.

Author

Kawaguchi, Y., Hasegawa, K., Tzeng, C.‐W. D., Mizuno, T., Arita, J., Sakamoto, Y., Chun, Y. S., Aloia, T. A., Kokudo, N., and Vauthey, J.‐N.

Subjects
LIVER, LIVER surgery, LAPAROSCOPIC surgery, CLASSIFICATION, HEPATECTOMY, DISEASES
Abstract

Copyright of British Journal of Surgery is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2020
Full Text
View/download PDF

34. Effects of Preoptic Injection of Glucagon on Luteinizing Hormone Secretion in Ovariectomized Rats with or without Estrogen Priming

Author

Fukuko Kimura, Hashimoto R, Mitsugi N, Arita J, and Yoshida K

Subjects
endocrine system, medicine.medical_specialty, medicine.drug_class, Ovariectomy, Endocrinology, Diabetes and Metabolism, Gastric Inhibitory Polypeptide, Biology, Glucagon, Injections, Endocrinology, Internal medicine, Internal Medicine, medicine, Animals, Luteinizing hormone secretion, digestive, oral, and skin physiology, Estrogens, Rats, Inbred Strains, General Medicine, Luteinizing Hormone, Prolactin, Rats, Preoptic area, Estrogen, Ovariectomized rat, Female, Gonadotropin, Luteinizing hormone, hormones, hormone substitutes, and hormone antagonists
Abstract

Effects of microinjection of glucagon or GIP into the medial preoptic area on luteinizing hormone (LH) and prolactin (PRL) release were examined in unanesthetized ovariectomized rats with or without estrogen priming. Microinjection of glucagon (1.0 microgram) into the medial preoptic area of ovariectomized estrogen-primed rats significantly facilitated the circadian afternoon rise in LH secretion as compared to the hormone values in control animals microinjected with physiological saline. The timing of the afternoon LH rise was not altered by glucagon and the circadian rise of PRL secretion was not altered by glucagon injected in the preoptic area. The injection of GIP did not have any significant effect on either LH or PRL secretion. In ovariectomized estrogen-unprimed rats, on the other hand, glucagon did not affect the pulsatile LH secretion, but it inhibited PRL secretion. GIP did not affect any hormone secretion. The results show that (1) glucagon, as other secretion family peptides such as secretion and PHI, can stimulate the preoptic LH secretory mechanism that undergoes the circadian clock mechanism under the influence of estrogen, and (2) without estrogen priming, glucagon in the preoptic area inhibits PRL secretion.

Published
2009
Full Text
View/download PDF

43. Intravenous gammaglobulin therapy of Satoyoshi syndrome

Author

Shin-ichiro Hamano, Arita J, Takahiro Nara, and Kihei Maekawa

Subjects
medicine.medical_specialty, Anti-nuclear antibody, medicine.medical_treatment, Gastroenterology, Developmental Neuroscience, Internal medicine, medicine, Humans, Growth Plate, Child, skin and connective tissue diseases, Chemotherapy, Satoyoshi syndrome, business.industry, Alopecia, Gamma globulin, Syndrome, General Medicine, medicine.disease, Magnetic Resonance Imaging, stomatognathic diseases, Intermittent painful muscle spasms, Diarrhea, Muscle Spasticity, Pediatrics, Perinatology and Child Health, Immunology, Etiology, Female, Immunotherapy, gamma-Globulins, Neurology (clinical), medicine.symptom, business, Cartilage Diseases, Rare disease
Abstract

Satoyoshi syndrome is a very rare disease of unknown etiology, characterized by intermittent painful muscle spasms, alopecia, multiple epiphyseal changes, diarrhea and endocrine disorders. We administered intravenous gammaglobulin to a 7-year-old girl with Satoyoshi syndrome. Frequency of muscle spasms and the titers of antinuclear antibody and anti-DNA antibody decreased. This is the first report of gammaglobulin therapy of Satoyoshi syndrome. We suggest that this illness could be related to an autoimmune mechanism.

Published
1996
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results